Evidence map›Paper›PMID 35587312›Full record

ArticleActa neurologica Belgica2023

SMART syndrome: a case report.

Saliha Bozkurt, Berna Toprak, Hasan Çağrı Yıldırım, Şafak Parlak, Deniz Can Güven, Neyran Kertmen, Kader Karlı Oğuz, Ömer Dizdar

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. SMART Syndrome: Case Report and Review of the Literature.Journal of the Belgian Society of Radiology · 2023
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Saliha BozkurtDepartment of Internal Medicine, Hacettepe University, Ankara, Turkey.
Berna ToprakDepartment of Internal Medicine, Hacettepe University, Ankara, Turkey.
Hasan Çağrı YıldırımDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. hasan-cagri@windowslive.com.ORCID http://orcid.org/0000-0003-3060-377X
Şafak ParlakDepartment of Radiology, Hacettepe University, Ankara, Turkey.
Deniz Can GüvenDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Neyran KertmenDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Kader Karlı OğuzDepartment of Radiology, Hacettepe University, Ankara, Turkey.
Ömer DizdarDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Hacettepe University · TRHacettepe University Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionStroke-like migraine attacks after radiation therapy (SMART) syndrome, is a late complication of brain radiotherapy (1). Symptoms are commonly subacute in onset and involve migraine type of headache, seizures, focal neurologic deficits (2). Magnetic resonance imaging (MRI) findings are usually unilateral and posterior predominant cortical-subcortical hyperintensity, swelling and prominent gyriform (cortical and leptomeningeal) gadolinium enhancement in the areas of the brain that underwent irradiation with or without diffusion restriction (1). There is no standard treatment protocol for SMART syndrome. Antiepileptics and corticosteroids are commonly used drugs. CASE REPORT: A 65 years old woman was diagnosed with breast cancer with brain metastases and treated with more than 50 Gy brain radiotherapy. The patient presented with acute right-sided weakness and numbness, episodic myoclonic jerking of the right arm and leg, and gait instability five months later. MRI and magnetic resonance angiography of the brain with gadolinium revealed left parietooccipital cortical diffusion restriction and accompanying dilatation of the left posterior cerebral artery as new findings. Computed tomography (CT) perfusion revealed increased perfusion in the affected area. The patient was diagnosed with SMART syndrome. MANAGEMENT AND OUTCOME: The patient was treated with dexamethasone (16 mg/day) and anticonvulsant therapy. Myoclonic seizures had almost completely remitted. However, her cognitive impairment persisted, then the patient was arrested because of aspiration a month later. DISCUSSION: Besides confirming SMART syndrome, diagnostic investigations are also important to exclude other etiologies. Posterior reversible encephalopathy syndrome, post-ictal changes, meningoencephalitis, and cerebrovascular diseases are radiological differential diagnoses considered (3). Proper and early diagnosis of SMART syndrome is significant in preventing unnecessary aggressive approaches and appropriate treatment to avoid lesions of sequela.

Indexed as

Migraine DisordersPosterior Leukoencephalopathy SyndromeAgedBrainContrast MediaFemaleGadoliniumHumansMagnetic Resonance ImagingContrast MediaGadoliniumBrain radiationStroke-like migraine attacks after radiation therapy

Identifiers

PMID35587312
OpenAlexW4280491290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.